# Echinaforce Junior Bioavailability Trial

> **NCT03070314** · PHASE4 · WITHDRAWN · sponsor: **A. Vogel AG**

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Echinaforce junior

## Key facts

- **NCT ID:** NCT03070314
- **Lead sponsor:** A. Vogel AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-02-20
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participants could be recruited who were eager to donate blood for bioavailability despite prolongation of the study period.
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070314, "Echinaforce Junior Bioavailability Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03070314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*